ViiV Healthcare sponsored events to address the climbing rates of HIV infections on HBCU campuses and the surrounding Black ...

Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and ...

ViiV Healthcare has announced plans to triple its annual supply of long-acting cabotegravir for HIV pre-exposure prophylaxis ...

Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...

ViiV’s strategy for CAB LA for PrEP in L&MICs is to maximise rapid access and uptake for populations with highest unmet needs ...

Alabama State University partnered with ViiV Healthcare during its 2024 Homecoming to address HIV prevention and awareness.

ViiV Healthcare’s latest HIV prevention campaign coincided with one of the biggest weekends of the year at Alabama State University.

ViiV Healthcare, a GSK-majority-owned HIV specialist, has committed to making at least two million doses of its long-acting ...

On the campus of Alabama State University, ViiV Healthcare transformed the annual celebration into a platform for HIV ...

Responding to ViiV's announcement on long-acting cabotegravir , UNAIDS Executive Director Winnie Byanyima said:"New HIV ...

Note: ViiV’s announcement can be read on their site at ...

GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | ...